Jaguar Health Files 8-K: Regulatory, Other Events & Financials

Ticker: JAGX · Form: 8-K · Filed: Apr 4, 2025 · CIK: 1585608

Sentiment: neutral

Topics: 8-K, regulatory-disclosure, financials

Related Tickers: JAGX

TL;DR

Jaguar Health (JAGX) filed an 8-K on 3/31, covering Reg FD, other events, and financials. Check for updates.

AI Summary

Jaguar Health, Inc. filed an 8-K on April 4, 2025, reporting events as of March 31, 2025. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company, formerly known as Jaguar Animal Health, Inc., is incorporated in Delaware and headquartered in San Francisco, California.

Why It Matters

This 8-K filing provides crucial updates on Jaguar Health's regulatory disclosures, other significant events, and financial statements, offering insights into the company's current operational and financial status.

Risk Assessment

Risk Level: medium — 8-K filings can contain material information, but the specific content here is broad, requiring further analysis to determine precise risk implications.

Key Numbers

Key Players & Entities

FAQ

What specific 'Other Events' are detailed in this 8-K filing?

The provided text does not specify the 'Other Events'; it only lists the category as part of the filing's content.

What is the primary business of Jaguar Health, Inc.?

Jaguar Health, Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.

When did Jaguar Health, Inc. change its name from Jaguar Animal Health, Inc.?

The date of the name change was August 30, 2013.

What is the principal executive office address for Jaguar Health, Inc.?

The principal executive offices are located at 200 Pine Street Suite 400, San Francisco, California 94104.

What is the filing date of this 8-K report?

This 8-K report was filed on April 4, 2025.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 4, 2025 regarding Jaguar Health, Inc. (JAGX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing